| Literature DB >> 33356773 |
Sihyung Lee1, Moto Kuniko1, Seungah Han2, Taewoong Oh2, Motoko Taguchi3.
Abstract
Low energy availability (EA) can impair physiological function in athletes. The purpose of this study was to investigate EA status, metabolic status, and bone metabolism with biochemical analysis in Korean male soccer players. Twelve male athletes (18-20 years) completed the study. Body composition and bone mineral density were measured using dual energy X-ray absorptiometry (DXA), while VO2 max was determined by an incremental exercise test. Blood samples were taken for bone marker and hormone analyses. Resting energy expenditure (REE) was measured using the Douglas bag method and predicted using the DXA method. Food diaries and heart rates (HR) during training were recorded, and the Profile of Mood States 2 and Eating Attitude Test 26 were completed. Group differences between low EA (LEA <30 kcal/kg FFM/d, n = 5) and high EA (HEA ≥30 kcal/kg FFM/d, n = 7) were evaluated. The mean EA of the all participants was 31.9 ± 9.8 kcal/kg FFM/d with only two participants having an EA above 45 kcal/kg FFM/d. LEA showed suppressed REE (LEA: 26.0 ± 1.7 kcal/kg/d, HEA: 28.8 ± 1.4 kcal/kg/d, p = .011) with a lower REEratio (LEA: 0.91 ± 0.06, HEA: 1.01 ± 0.05, p = .008) as well as a lower insulin-like growth factor 1 (IGF-1) level (LEA: 248.6 ± 51.2 ng/mL, HEA: 318.9 ± 43.4 ng/mL, p = .028) compared to HEA. There were no group differences in bone markers or other hormone levels. Korean male athletes exhibited low EA status with suppressed metabolism, but there was limited evidence on the effect of EA on bone metabolism, endocrine system, and psychological parameters.Entities:
Keywords: Energy deficiency; male athletes; metabolism
Year: 2020 PMID: 33356773 PMCID: PMC7768860 DOI: 10.1177/1557988320982186
Source DB: PubMed Journal: Am J Mens Health ISSN: 1557-9883
Descriptive Characteristics of the Participants.
| Total ( | LEA ( | HEA ( | ||
|---|---|---|---|---|
| Age (years) | 19.0 (19.0−19.5) | 19.0 (19.0−19.0) | 19.0 (18.0−20.0) | .647 |
| Height (cm) | 175.8 ± 5.1 | 178.4 ± 6.7 | 173.9 ± 2.9 | .212 |
| Body mass (kg) | 69.61 ± 5.79 | 72.70 ± 7.10 | 67.40 ± 3.78 | .122 |
| BMI (kg/m2) | 22.5 ± 1.2 | 22.8 ± 1.2 | 22.3 ± 1.3 | .488 |
| Body fat (kg) | 9.5 ± 2.3 | 8.7 (8.0−8.9) | 9.1 (8.1−11.6) | .685 |
| Body fat (%) | 13.6 ± 2.6 | 12.0 (11.4−12.3) | 13.3 (13.0−16.2) | .254 |
| FFM (kg) | 60.1 ± 4.5 | 63.2 ± 4.5 | 57.9 ± 3.2 | .037 |
| BMD (g/cm2) | 1.384 ± 0.075 | 1.396 ± 0.091 | 1.376 ± 0.068 | .677 |
| VO2 max (ml/kg/min) | 54.9 ± 5.7 | 57.7 ± 6.8 | 52.9 ± 4.2 | .152 |
Note. Normally distributed data were presented as mean ± SD, and non-normally distributed data were reported by median (interquartile range). BMI = body mass index, FFM = fat-free mass, BMD = bone mineral density.
EA and REE-Related Parameters of the Participants.
| Total ( | LEA ( | HEA ( | ||
|---|---|---|---|---|
| EI (kcal/d) | 3,456 ± 435 | 3,114 ± 297 | 3,701 ± 348 | .012 |
| EEE (kcal/d) | 1,747 ± 334 | 1,890 ± 154 | 1,645 ± 400 | .226 |
| EA (kcal/kg FFM/d) | 31.9 ± 9.8 | 22.4 ± 2.9 | 38.7 ± 6.6 | <.001 |
| REE | ||||
| REEm (kcal/d) | 1,654 ± 129 | 1,636 ± 112 | 1,668 ± 147 | .691 |
| REE/FFM (kcal/kg/d) | 27.6 ± 2.1 | 26.0 ± 1.7 | 28.8 ± 1.4 | .011 |
| REEp (kcal/d) | 1,715 ± 114 | 1,805 ± 82 | 1,651 ± 88 | .012 |
| REEratio (REEm/REEp) | 0.97 ± 0.07 | 0.91 ± 0.06 | 1.01 ± 0.05 | .008 |
Note. Normally distributed data were presented as mean ± SD. EA = energy availability, EI = energy intake, EEE = exercise energy expenditure, REE = resting energy expenditure, REEm = measured resting energy expenditure, REEp = predicted resting energy expenditure.
Bone Turnover Markers and Hormone Levels of the Participants.
| Total ( | LEA ( | HEA ( | Reference value | ||
|---|---|---|---|---|---|
| Bone metabolism | |||||
| s-BAP (μg/L) | 23.9 ± 6.5 | 21.4 ± 4.9 | 25.7 ± 7.3 | 0.289 | <20.1 |
| s-CTx (ng/mL) | 0.93 ± 0.18 | 0.93 ± 0.16 | 0.92 ± 0.20 | 0.920 | 0.05−0.45 |
| Hormone | |||||
| FSH (mIU/mL) | 4.42 ± 1.54 | 5.50 ± 1.01 | 3.64 ± 1.41 | 0.031 | 1.5−12.4 |
| LH (mIU/mL) | 5.08 ± 1.93 | 5.96 ± 1.05 | 4.46 ± 2.24 | 0.197 | 1.7−8.6 |
| Testosterone (ng/mL) | 8.06 ± 2.19 | 8.72 ± 1.81 | 7.58 ± 2.44 | 0.401 | 2.40−8.71 |
| Estradiol (pg/mL) | 40.0 | 34.0 | 42.0 | 0.251 | 5.2−43.9 |
| GH (ng/mL) | 7.77 ± 7.31 | 7.16 ± 7.26 | 8.20 ± 7.89 | 0.819 | ≤3.0 |
| IGF-1 (ng/mL) | 289.6 ± 57.3 | 248.6 ± 51.2 | 318.9 ± 43.4 | 0.028 | 247.3−481.7 |
| Cortisol (μg/L) | 11.2 ± 3.2 | 10.6 ± 4.4 | 11.6 ± 2.2 | 0.676 | 3.7−19.4 |
| T3 (ng/mL) | 1.06 ± 0.16 | 1.02 ± 0.13 | 1.09 ± 0.18 | 0.500 | 0.8−2.0 |
| Leptin (ng/mL) | 2.2 ± 0.9 | 1.9 ± 0.8 | 2.3 ± 1.0 | 0.484 | |
Note. Normally distributed data were presented as mean ± SD, and non-normally distributed data were reported by median (interquartile range). s-BAP = serum bone alkaline phosphatase, s-CTx = serum C-terminal telopeptide of type 1 collagen, FSH = follicle stimulating hormone, LH = luteinizing hormone, GH = growth hormone, IGF-1 = insulin-like growth factor 1, T3 = triiodothyronine.
POMS-2 and EAT-26 Scores of the Participants.
| Total ( | LEA ( | HEA ( | ||
|---|---|---|---|---|
| POMS-2 | 3.4 ± 8.3 | 0.6 ± 5.1 | 5.4 ± 9.9 | .345 |
| Anger-Hostility | 1.7 ± 1.4 | 2.6 ± 1.5 | 1.0 ± 1.0 | .051 |
| Confusion-Bewilderment | 2.9 ± 2.2 | 2.2 ± 1.6 | 3.4 ± 2.5 | .363 |
| Depression-Dejection | 0.5 (0.0−2.0) | 0.0 (0.0−2.0) | 1.0 (0.0−2.0) | .718 |
| Fatigue-Inertia | 7.1 ± 3.3 | 6.8 ± 2.5 | 7.3 ± 4.0 | .817 |
| Tension-Anxiety | 3.0 ± 2.3 | 2.4 ± 2.1 | 3.4 ± 2.5 | .471 |
| Vigor-Activity | 12.2 ± 3.4 | 14.2 ± 3.4 | 10.7 ± 2.6 | .073 |
| Friendliness | 11.5 (11.0−13.0) | 13.0 (12.0−14.0) | 11.0 (10.0−11.0) | .013 |
| EAT-26 | 3.8 ± 1.8 | 4.2 ± 1.3 | 3.4 ± 2.1 | .482 |
Note. Normally distributed data were presented as mean ± SD, and non-normally distributed data were reported by median (interquartile range). POMS-2 = profile of mood states 2, EAT-26 = eating attitude test 26.